554 related articles for article (PubMed ID: 34922544)
1. CircIL4R activates the PI3K/AKT signaling pathway via the miR-761/TRIM29/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer.
Jiang T; Wang H; Liu L; Song H; Zhang Y; Wang J; Liu L; Xu T; Fan R; Xu Y; Wang S; Shi L; Zheng L; Wang R; Song J
Mol Cancer; 2021 Dec; 20(1):167. PubMed ID: 34922544
[TBL] [Abstract][Full Text] [Related]
2. CircRNA_0000392 promotes colorectal cancer progression through the miR-193a-5p/PIK3R3/AKT axis.
Xu H; Liu Y; Cheng P; Wang C; Liu Y; Zhou W; Xu Y; Ji G
J Exp Clin Cancer Res; 2020 Dec; 39(1):283. PubMed ID: 33317596
[TBL] [Abstract][Full Text] [Related]
3. LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway.
Liu B; Pan S; Xiao Y; Liu Q; Xu J; Jia L
J Exp Clin Cancer Res; 2018 Dec; 37(1):316. PubMed ID: 30547804
[TBL] [Abstract][Full Text] [Related]
4. MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling.
Chen X; Wang W; Li Y; Huo Y; Zhang H; Feng F; Xi W; Zhang T; Gao J; Yang F; Chen S; Yang A; Wang T
J Exp Clin Cancer Res; 2021 Oct; 40(1):341. PubMed ID: 34706761
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
[TBL] [Abstract][Full Text] [Related]
6. Circ3823 contributes to growth, metastasis and angiogenesis of colorectal cancer: involvement of miR-30c-5p/TCF7 axis.
Guo Y; Guo Y; Chen C; Fan D; Wu X; Zhao L; Shao B; Sun Z; Ji Z
Mol Cancer; 2021 Jun; 20(1):93. PubMed ID: 34172072
[TBL] [Abstract][Full Text] [Related]
7. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-760 inhibits the biological progression of colorectal carcinoma by directly targeting FOXA1 and regulating epithelial-to-mesenchymal transition and PI3K/AKT signaling pathway.
Cong K; Li CG; Wei YH; Zhang K; Xu HB
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5730-5740. PubMed ID: 31298352
[TBL] [Abstract][Full Text] [Related]
9. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis.
Shang A; Gu C; Wang W; Wang X; Sun J; Zeng B; Chen C; Chang W; Ping Y; Ji P; Wu J; Quan W; Yao Y; Zhou Y; Sun Z; Li D
Mol Cancer; 2020 Jul; 19(1):117. PubMed ID: 32713345
[TBL] [Abstract][Full Text] [Related]
10. EIF4A3-induced circ_0084615 contributes to the progression of colorectal cancer via miR-599/ONECUT2 pathway.
Jiang Z; Tai Q; Xie X; Hou Z; Liu W; Yu Z; Liang Z; Chen S
J Exp Clin Cancer Res; 2021 Jul; 40(1):227. PubMed ID: 34253241
[TBL] [Abstract][Full Text] [Related]
11. The circular RNA circ-ERBIN promotes growth and metastasis of colorectal cancer by miR-125a-5p and miR-138-5p/4EBP-1 mediated cap-independent HIF-1α translation.
Chen LY; Wang L; Ren YX; Pang Z; Liu Y; Sun XD; Tu J; Zhi Z; Qin Y; Sun LN; Li JM
Mol Cancer; 2020 Nov; 19(1):164. PubMed ID: 33225938
[TBL] [Abstract][Full Text] [Related]
12. HOTAIR/miR-326/FUT6 axis facilitates colorectal cancer progression through regulating fucosylation of CD44 via PI3K/AKT/mTOR pathway.
Pan S; Liu Y; Liu Q; Xiao Y; Liu B; Ren X; Qi X; Zhou H; Zeng C; Jia L
Biochim Biophys Acta Mol Cell Res; 2019 May; 1866(5):750-760. PubMed ID: 30742932
[TBL] [Abstract][Full Text] [Related]
13. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
[TBL] [Abstract][Full Text] [Related]
14. ZNF460-mediated circRPPH1 promotes TNBC progression through ITGA5-induced FAK/PI3K/AKT activation in a ceRNA manner.
Zhang C; Yu Z; Yang S; Liu Y; Song J; Mao J; Li M; Zhao Y
Mol Cancer; 2024 Feb; 23(1):33. PubMed ID: 38355583
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression.
Li Y; Zeng C; Hu J; Pan Y; Shan Y; Liu B; Jia L
J Hematol Oncol; 2018 Jul; 11(1):89. PubMed ID: 29970122
[TBL] [Abstract][Full Text] [Related]
17. miR-182 and miR-135b Mediate the Tumorigenesis and Invasiveness of Colorectal Cancer Cells via Targeting ST6GALNAC2 and PI3K/AKT Pathway.
Jia L; Luo S; Ren X; Li Y; Hu J; Liu B; Zhao L; Shan Y; Zhou H
Dig Dis Sci; 2017 Dec; 62(12):3447-3459. PubMed ID: 29030743
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA circ_001422 promotes the progression and metastasis of osteosarcoma via the miR-195-5p/FGF2/PI3K/Akt axis.
Yang B; Li L; Tong G; Zeng Z; Tan J; Su Z; Liu Z; Lin J; Gao W; Chen J; Zeng S; Wu G; Li L; Zhu S; Liu Q; Lin L
J Exp Clin Cancer Res; 2021 Jul; 40(1):235. PubMed ID: 34271943
[TBL] [Abstract][Full Text] [Related]
19. Exosomal circTUBGCP4 promotes vascular endothelial cell tipping and colorectal cancer metastasis by activating Akt signaling pathway.
Chen C; Liu Y; Liu L; Si C; Xu Y; Wu X; Wang C; Sun Z; Kang Q
J Exp Clin Cancer Res; 2023 Feb; 42(1):46. PubMed ID: 36793126
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA RP11-757G1.5 sponges miR-139-5p and upregulates YAP1 thereby promoting the proliferation and liver, spleen metastasis of colorectal cancer.
Zhu X; Bu F; Tan T; Luo Q; Zhu J; Lin K; Huang J; Luo C; Zhu Z
J Exp Clin Cancer Res; 2020 Oct; 39(1):207. PubMed ID: 33023613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
